Scientists at the Department of Organic Chemistry at the Georg-August-University of Göttingen have developed a new compound class for the use in Boron-Neutron-Capture-Therapy (BNCT). This new class of substances allows using BNCT in a tissue and tumot specific manner.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
